Real-time enrollment status for this hypercholesterolaemia clinical trial
Current Status
Recruiting
Checked: September 10, 2026 at 9:29 PM UTC
| NCT Number | NCT07619131 |
| Recruiting Status | Recruiting |
| Condition | Hypercholesterolaemia |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 77 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | September 10, 2026 (21 hours ago) |
As of September 10, 2026: Clinical trial NCT07619131 is currently recruiting participants. This phase3 study for hypercholesterolaemia is actively seeking new participants at 77 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07619131 is actively recruiting participants as of September 10, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 77 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07619131 was last updated 21 hours ago (September 10, 2026). HelloStudys verifies this status automatically.